Cargando…

A mainstreaming oncogenomics model: improving the identification of Lynch syndrome

INTRODUCTION: “Mainstreaming” is a proposed strategy to integrate genomic testing into oncology. The aim of this paper is to develop a mainstreaming oncogenomics model by identifying health system interventions and implementation strategies for mainstreaming Lynch syndrome genomic testing. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Shea, Rosie, Crook, Ashley, Jacobs, Chris, Kentwell, Maira, Gleeson, Margaret, Tucker, Katherine M., Hampel, Heather, Rahm, Alanna Kulchak, Taylor, Natalie, Lewis, Sarah, Rankin, Nicole M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256118/
https://www.ncbi.nlm.nih.gov/pubmed/37305562
http://dx.doi.org/10.3389/fonc.2023.1140135
_version_ 1785057036524847104
author O’Shea, Rosie
Crook, Ashley
Jacobs, Chris
Kentwell, Maira
Gleeson, Margaret
Tucker, Katherine M.
Hampel, Heather
Rahm, Alanna Kulchak
Taylor, Natalie
Lewis, Sarah
Rankin, Nicole M.
author_facet O’Shea, Rosie
Crook, Ashley
Jacobs, Chris
Kentwell, Maira
Gleeson, Margaret
Tucker, Katherine M.
Hampel, Heather
Rahm, Alanna Kulchak
Taylor, Natalie
Lewis, Sarah
Rankin, Nicole M.
author_sort O’Shea, Rosie
collection PubMed
description INTRODUCTION: “Mainstreaming” is a proposed strategy to integrate genomic testing into oncology. The aim of this paper is to develop a mainstreaming oncogenomics model by identifying health system interventions and implementation strategies for mainstreaming Lynch syndrome genomic testing. METHODS: A rigorous theoretical approach inclusive of conducting a systematic review and qualitative and quantitative studies was undertaken using the Consolidated Framework for Implementation Research. Theory-informed implementation data were mapped to the Genomic Medicine Integrative Research framework to generate potential strategies. RESULTS: The systematic review identified a lack of theory-guided health system interventions and evaluation for Lynch syndrome and other mainstreaming programs. The qualitative study phase included 22 participants from 12 health organizations. The quantitative Lynch syndrome survey included 198 responses: 26% and 66% from genetic and oncology health professionals, respectively. Studies identified the relative advantage and clinical utility of mainstreaming to improve genetic test access and to streamline care, and adaptation of current processes was recognized for results delivery and follow-up. Barriers identified included funding, infrastructure and resources, and the need for process and role delineation. The interventions to overcome barriers were as follows: embedded mainstream genetic counselors, electronic medical record genetic test ordering, results tracking, and mainstreaming education resources. Implementation evidence was connected through the Genomic Medicine Integrative Research framework resulting in a mainstreaming oncogenomics model. DISCUSSION: The proposed mainstreaming oncogenomics model acts as a complex intervention. It features an adaptable suite of implementation strategies to inform Lynch syndrome and other hereditary cancer service delivery. Implementation and evaluation of the model are required in future research.
format Online
Article
Text
id pubmed-10256118
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102561182023-06-10 A mainstreaming oncogenomics model: improving the identification of Lynch syndrome O’Shea, Rosie Crook, Ashley Jacobs, Chris Kentwell, Maira Gleeson, Margaret Tucker, Katherine M. Hampel, Heather Rahm, Alanna Kulchak Taylor, Natalie Lewis, Sarah Rankin, Nicole M. Front Oncol Oncology INTRODUCTION: “Mainstreaming” is a proposed strategy to integrate genomic testing into oncology. The aim of this paper is to develop a mainstreaming oncogenomics model by identifying health system interventions and implementation strategies for mainstreaming Lynch syndrome genomic testing. METHODS: A rigorous theoretical approach inclusive of conducting a systematic review and qualitative and quantitative studies was undertaken using the Consolidated Framework for Implementation Research. Theory-informed implementation data were mapped to the Genomic Medicine Integrative Research framework to generate potential strategies. RESULTS: The systematic review identified a lack of theory-guided health system interventions and evaluation for Lynch syndrome and other mainstreaming programs. The qualitative study phase included 22 participants from 12 health organizations. The quantitative Lynch syndrome survey included 198 responses: 26% and 66% from genetic and oncology health professionals, respectively. Studies identified the relative advantage and clinical utility of mainstreaming to improve genetic test access and to streamline care, and adaptation of current processes was recognized for results delivery and follow-up. Barriers identified included funding, infrastructure and resources, and the need for process and role delineation. The interventions to overcome barriers were as follows: embedded mainstream genetic counselors, electronic medical record genetic test ordering, results tracking, and mainstreaming education resources. Implementation evidence was connected through the Genomic Medicine Integrative Research framework resulting in a mainstreaming oncogenomics model. DISCUSSION: The proposed mainstreaming oncogenomics model acts as a complex intervention. It features an adaptable suite of implementation strategies to inform Lynch syndrome and other hereditary cancer service delivery. Implementation and evaluation of the model are required in future research. Frontiers Media S.A. 2023-05-26 /pmc/articles/PMC10256118/ /pubmed/37305562 http://dx.doi.org/10.3389/fonc.2023.1140135 Text en Copyright © 2023 O’Shea, Crook, Jacobs, Kentwell, Gleeson, Tucker, Hampel, Rahm, Taylor, Lewis and Rankin https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
O’Shea, Rosie
Crook, Ashley
Jacobs, Chris
Kentwell, Maira
Gleeson, Margaret
Tucker, Katherine M.
Hampel, Heather
Rahm, Alanna Kulchak
Taylor, Natalie
Lewis, Sarah
Rankin, Nicole M.
A mainstreaming oncogenomics model: improving the identification of Lynch syndrome
title A mainstreaming oncogenomics model: improving the identification of Lynch syndrome
title_full A mainstreaming oncogenomics model: improving the identification of Lynch syndrome
title_fullStr A mainstreaming oncogenomics model: improving the identification of Lynch syndrome
title_full_unstemmed A mainstreaming oncogenomics model: improving the identification of Lynch syndrome
title_short A mainstreaming oncogenomics model: improving the identification of Lynch syndrome
title_sort mainstreaming oncogenomics model: improving the identification of lynch syndrome
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256118/
https://www.ncbi.nlm.nih.gov/pubmed/37305562
http://dx.doi.org/10.3389/fonc.2023.1140135
work_keys_str_mv AT oshearosie amainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome
AT crookashley amainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome
AT jacobschris amainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome
AT kentwellmaira amainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome
AT gleesonmargaret amainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome
AT tuckerkatherinem amainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome
AT hampelheather amainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome
AT rahmalannakulchak amainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome
AT taylornatalie amainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome
AT lewissarah amainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome
AT rankinnicolem amainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome
AT oshearosie mainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome
AT crookashley mainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome
AT jacobschris mainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome
AT kentwellmaira mainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome
AT gleesonmargaret mainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome
AT tuckerkatherinem mainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome
AT hampelheather mainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome
AT rahmalannakulchak mainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome
AT taylornatalie mainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome
AT lewissarah mainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome
AT rankinnicolem mainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome